Resultados de la búsqueda 171-180 of 2094 for Maximum

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of ...

  3. Oncología (médica) - Ensayos clínicos

    The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of ...

  4. Oncología (médica) - Ensayos clínicos

    ... maximum tolerated dose (MTD), identify a recommended phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity. A Study to ...

  5. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of ...

  7. Oncología (médica) - Ensayos clínicos

    ... maximum) over a period of 12 months * Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 weeks of cycle 1 ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  9. Medicina pulmonar - Ensayos clínicos

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

  10. Ensayos clínicos - Neurología

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...